BioAscent has confirmed it will be exhibiting at the 7th RSC-BMCS Fragment-based drug discovery meeting which is being held on the 24th – 26th March at Churchill College in Cambridge.
The meeting will focus on case studies in fragment-based drug discovery that have delivered compounds to late stage medicinal chemistry, preclinical or clinical programmes. The event will include successful examples from all types of fragment-based approaches, including high concentration, NMR, SPR and x-ray screening.
BioAscent’s Director of Chemistry, Angus Morrison will be attending the meeting and available to talk to any delegates about integrated drug discovery (including fragment-based approaches) and compound management services.
For more information, click here.